Kolibri Global Energy Inc. Announces Another Record for Its Highest Quarterly Revenue of $22.5 Million With a 46% Production Increase and a 197% Net Income Increase for the Second Quarter of 2026

Kolibri Global Energy Inc. reported Q2 2026 revenue net of royalties of $22.5 million, up from $10.8 million a year earlier, driven by 46% higher production to 4,690 BOEPD and 41% higher average prices. Net income rose to $8.5 million (basic EPS $0.24) and Adjusted EBITDA to $16.4 million. At June 30, 2026 it had $30.5 million available under a $75 million credit facility.

Original reporting
Published Aug 13, 2026, 11:15 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 13, 2026, 11:25 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
MARKET
Neutral
AI market analysis
Mentioned
$KGEI
Relevance
7/10
alphai data visualization · based on finanznachrichten.de
Decision brief

The 30-second read

Med
01

Why it matters

Traders can use the quantified quarter metrics and the stated operational timeline (fracture stimulation and expected production timing) to update near-term production and earnings expectations, while monitoring commodity-contract losses and cost inflation.

02

Market read

A quantified earnings and operations update with a near-term execution catalyst, likely supporting positive sentiment into the scheduled investor call.

03

What to watch

Production mix shifts (gas purchaser reassessments to NGLs) and temporary shut-ins near Clifton Mack completion may create quarter-to-quarter volatility not captured by headline growth rates.

Relevance 7/10Novelty 6/10Timing: earnings conference call scheduled for 9:00 a.m. Pacific today

Background

Kolibri Global Energy’s Q2 2026 results emphasize production growth from wells drilled/completed in late 2025 and higher realized prices, with additional operational updates for Clifton Mack and upcoming Lovina 8-5-1HF drilling.

Market effects

Reinforces the narrative that small US E&Ps can show outsized growth via drilling conversion and pricing, but highlights ongoing commodity-hedge/contract P&L volatility.

No explicit regional macro or basin-wide catalyst beyond company-specific well activity.

Limited, company-specific upstream performance with no direct global linkage.

Counterpoint

Despite strong top-line and net income growth, realized losses on commodity contracts and higher operating and depletion costs could cap sustainability if prices or hedges move against the company.

Key entities

  • Kolibri Global Energy Inc.

    US-listed upstream oil and gas producer reporting Q2 2026 revenue, production, net income, and operational progress plus upcoming well activity.

  • Clifton Mack wells

    Three wells where drilling is completed and fracture stimulation is expected to begin this month, with production expected during end of Q3.

  • Alicia Renee wells

    Three wells temporarily shut in for about 30 days during the quarter, expected to resume once Clifton Mack completion operations are complete.

  • Lovina 8-5-1HF well

    Planned drilling to test the False Caney bench and the company’s first 2-mile lateral well.

Related articles

$ARCTMedAI 8/10

Arcturus (ARCT) Q2 2026 Earnings Call Transcript

Arcturus Therapeutics (ARCT) reported Q2 2026 revenue of $3M ($5M for six months) versus $28.3M and $57.7M a year earlier, citing lower recognition tied to the CSL Seqirus collaboration termination process. Net loss was $23.8M ($0.84/share). Cash was $191.5M, with a runway through 2028. Company regained global rights to KOSTAIVE and received a $12M one-time payment. Phase II ARCT-032 enrollment continues, with a Phase III decision expected in Q4 2026.

$AMPHMedAI 8/10

Amphastar (AMPH) Q2 2026 Earnings Call Transcript

Amphastar (AMPH) reported Q2 2026 net revenues of $183.9 million, up 5% from $174.4 million, and gross margin of 50.8% versus 49.6%. GAAP net income was $30.3 million ($0.67/share). Adjusted non-GAAP net income was $40.8 million ($0.91/share). IMS remediation tied to an FDA warning letter is expected to add $2 million to $3 million per quarter, while full-year sales growth guidance remains mid-single digit to high single digit.

$JDMedAI 8/10

JD.com (JD) Q2 2026 Earnings Call Transcript

JD.com reported Q2 2026 results on an earnings call. Net revenues were RMB 346.4 billion, down 2.9% YoY. Non-GAAP net income rose 20.8% to RMB 8.9 billion, with JD Retail gross margin at 18.5% and operating margin at 4.6%. Free cash flow was RMB 31.8 billion, and JD repurchased $1 billion of Class A shares in H1 2026.

$HYPRMedAI 8/10

Hyperfine (HYPR) Q2 2026 Earnings Call Transcript

Hyperfine (HYPR) reported Q2 2026 revenue of $3.9 million, up 45% year over year, and first-half revenue of $7.8 million, up 62%. Gross margin was 50.7%. Net loss was $9.3 million. Cash was $43.5 million at June 30, 2026. Full-year 2026 guidance: revenue $20-$22 million, gross margin 50%-55%, cash burn $26-$28 million.

$CRSRHighAI 9/10

Corsair (CRSR) Q2 2026 Earnings Call Transcript

Corsair Gaming (CRSR) reported Q2 2026 revenue of $314.3 million, down 2% year over year, with GAAP gross margin at 33.2%. Peripherals revenue rose to $115.9 million (+13%). GAAP net income was $9.1 million and non-GAAP diluted EPS was $0.23. Q3 guidance: revenue $320M-$350M and adjusted EBITDA $18M-$21M. Full-year revenue raised to $1.4B-$1.47B.

$MCHPHighAI 9/10

Microchip (MCHP) Q1 2027 Earnings Call Transcript

Microchip Technology (MCHP) reported Q1 FY2027 net sales of $1.485B, up 13.2% sequentially and 38.0% YoY, with non-GAAP gross margin of 63.8% and non-GAAP diluted EPS of $0.76. Management guided September quarter net sales to $1.589B-$1.618B and non-GAAP gross margin to 66%-67%, citing inventory normalization and demand in data center and defense.